A Study to Evaluate Seroprevalence and Seroconversion of Antibodies to Adeno-Associated Virus (AAV) in Patients With Hemophilia A
Clinical trial NCT04560933 · COMPLETED
Trial details
- NCT number
- NCT04560933
- Sponsor
- BioMarin Pharmaceutical
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-08-25
- Primary completion
- 2023-09-20
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.